首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports
【24h】

Presence of multiple bacterial markers in clinical samples might be useful for presumptive diagnosis of infection in cirrhotic patients with culture-negative reports

机译:临床样本阴性的肝硬化患者中可能存在多种细菌标记物,有助于推测性诊断感染

获取原文
获取原文并翻译 | 示例
           

摘要

Bacterial infections in cirrhotic patients with ascites are associated with a severe prognosis and an increased risk of death. The microbiological standard tests for the diagnosis of suspected infection, based on culture test of blood and ascitic fluid, are, in many cases (30-40 %), negative, even when patients show symptoms of infection. A multiple culture-independent protocol was applied and evaluated as a diagnostic and prognostic tool for the detection of bacterial infection in cirrhotic patients. Sixty-four culture-negative samples obtained from 34 cirrhotic patients, with PMN < 250 cells/mu l of ascitic fluid, were screened for the presence of bacterial DNA, endotoxin, peptidoglycan/beta-glucan and microscopically visible bacterial cells. Correlations between the presence of multiple markers and various clinical and laboratory parameters were evaluated. Bacterial DNA was detected in 23 samples collected from 16 patients; a large part of these samples also showed the presence of other bacterial markers, which was associated with a worsening of liver functionality, a higher incidence of infections during the follow-up and a higher mortality rate in our cohort of cirrhotic patients. We believe that the detection of additional bacterial markers in bacterial DNA-positive clinical samples makes the bacterial presence and its clinical significance more realistic and might be useful as early markers of an ongoing bacterial infection and in establishing a clinical prognosis.
机译:肝硬化腹水患者的细菌感染与严重的预后和增加的死亡风险有关。在许多情况下(30-40%),即使当患者表现出感染症状时,基于血液和腹水的培养试验,用于诊断可疑感染的微生物标准试验仍呈阴性。应用了多种文化无关的协议,并将其评估为用于检测肝硬化患者细菌感染的诊断和预后工具。筛选34名肝硬化患者的PMN <250细胞/μl腹水的培养阴性样品,筛选细菌DNA,内毒素,肽聚糖/β-葡聚糖和显微镜下可见的细菌细胞的存在。评价了多种标记物的存在与各种临床和实验室参数之间的相关性。在从16例患者中收集的23份样品中检测到细菌DNA。这些样本中的很大一部分还显示存在其他细菌标记物,这与肝功能恶化,随访期间感染的发生率较高以及我们的肝硬化患者队列中较高的死亡率有关。我们相信,在细菌DNA阳性临床样品中检测其他细菌标志物会使细菌的存在及其临床意义更加现实,并且可能用作正在进行的细菌感染的早期标志物并建立临床预后。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号